AG
IONS icon

Algert Global’s Ionis Pharmaceuticals IONS Stock Holding History

Algert Global’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.75M Sell
116,563
-10,642
-8% -$840K 0.13% 249
2025
Q4 		$10.1M Sell
127,205
-125,076
-50% -$9.42M 0.16% 192
2025
Q3 		$16.5M Buy
252,281
+214,191
+562% +$10.5M 0.28% 75
2025
Q2 		$1.5M Buy
+38,090
New +$1.25M 0.03% 712
2024
Q4 		– Sell
-45,430
Closed -$1.82M – 1246
2024
Q3 		$1.82M Sell
45,430
-29,920
-40% -$1.39M 0.05% 581
2024
Q2 		$3.59M Buy
75,350
+45,108
+149% +$1.85M 0.12% 270
2024
Q1 		$1.31M Buy
30,242
+12,830
+74% +$612K 0.05% 544
2023
Q4 		$881K Sell
17,412
-28,110
-62% -$1.35M 0.04% 653
2023
Q3 		$2.06M Sell
45,522
-3,730
-8% -$154K 0.1% 353
2023
Q2 		$2.02M Sell
49,252
-9,400
-16% -$361K 0.09% 381
2023
Q1 		$2.1M Sell
58,652
-14,895
-20% -$559K 0.1% 328
2022
Q4 		$2.78M Buy
73,547
+12,610
+21% +$530K 0.15% 196
2022
Q3 		$2.69M Buy
60,937
+36,037
+145% +$1.52M 0.16% 183
2022
Q2 		$922K Buy
24,900
+11,556
+87% +$436K 0.07% 519
2022
Q1 		$494K Sell
13,344
-25,086
-65% -$821K 0.03% 818
2021
Q4 		$1.17M Buy
38,430
+14,956
+64% +$471K 0.15% 230
2021
Q3 		$787K Buy
+23,474
New +$884K 0.1% 348
2015
Q4 		– Sell
-6,390
Closed -$258K – 346
2015
Q3 		$258K Buy
+6,390
New +$331K 0.14% 238

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Algert Global's IONS Position: Q1 2026 in Review

Algert Global reduced its Ionis Pharmaceuticals (IONS) stake by 8.4% in Q1 2026, selling an estimated $840K and leaving 116,563 shares worth $8.75M. The position accounts for 0.13% of the portfolio, ranked #249.

Algert Global first reported a position in IONS in Q3 2015 and has held it in 18 quarters since. The position peaked at $16.5M in Q3 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Algert Global held 116,563 shares of Ionis Pharmaceuticals worth $8.75M as of Q1 2026.
  • Algert Global sold 10,642 Ionis Pharmaceuticals shares in Q1 2026, an estimated $840K.
  • Ionis Pharmaceuticals made up 0.13% of Algert Global's portfolio in Q1 2026, its #249 holding.
  • Algert Global first reported a position in Ionis Pharmaceuticals in Q3 2015 and has held it in 18 quarters since.
  • Algert Global's Ionis Pharmaceuticals position peaked at $16.5M in Q3 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.